▶ 調査レポート

世界の感染予防&経腸アクセス市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Infection Prevention and Enteral Access Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の感染予防&経腸アクセス市場 2021:企業別、地域別、種類・用途別 / Global Infection Prevention and Enteral Access Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-2104Z07638資料のイメージです。• レポートコード:GIR-2104Z07638
• 出版社/出版日:GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療機器・消耗品
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、感染予防&経腸アクセスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。感染予防&経腸アクセスの種類別市場規模(経腸栄養ポンプ、経腸栄養チューブ、投与リザーバー、ギビングセット、経腸注射器)、用途別市場規模(腫瘍、消化器病、糖尿病、神経障害、代謝亢進、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・感染予防&経腸アクセスの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Cook Medical、Medtronic Plc、Boston Scientific Corporation、CONMED Corporation、CORPAK MedSystems、CR Bard、ALCOR Scientific、Pacific Hospital Supply、Teleflexorporated、Vygon SA
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:経腸栄養ポンプ、経腸栄養チューブ、投与リザーバー、ギビングセット、経腸注射器
・用途別分析2016年-2026年:腫瘍、消化器病、糖尿病、神経障害、代謝亢進、その他
・感染予防&経腸アクセスの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・感染予防&経腸アクセスのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・感染予防&経腸アクセスのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・感染予防&経腸アクセスの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・感染予防&経腸アクセスの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Infection Prevention and Enteral Access market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Infection Prevention and Enteral Access size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Infection Prevention and Enteral Access market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Infection Prevention and Enteral Access market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Enteral Feeding Pumps
Enteral Feeding Tubes
Administration Reservoirs
Giving Sets
Enteral Syringes

Market segment by Application can be divided into
Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others

The key market players for global Infection Prevention and Enteral Access market are listed below:
Cook Medical
Medtronic Plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard
ALCOR Scientific
Pacific Hospital Supply
Teleflexorporated
Vygon SA

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Infection Prevention and Enteral Access Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Infection Prevention and Enteral Access Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Enteral Feeding Pumps
1.2.3 Enteral Feeding Tubes
1.2.4 Administration Reservoirs
1.2.5 Giving Sets
1.2.6 Enteral Syringes
1.3 Market Analysis by Application
1.3.1 Overview: Global Infection Prevention and Enteral Access Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Gastroenterology
1.3.4 Diabetes
1.3.5 Neurological Disorders
1.3.6 Hypermetabolism
1.3.7 Others
1.4 Global Infection Prevention and Enteral Access Market Size & Forecast
1.4.1 Global Infection Prevention and Enteral Access Sales in Value (2016-2026))
1.4.2 Global Infection Prevention and Enteral Access Sales in Volume (2016-2026)
1.4.3 Global Infection Prevention and Enteral Access Price by Type (2016-2026) & (USD/Unit)
1.5 Global Infection Prevention and Enteral Access Production Capacity Analysis
1.5.1 Global Infection Prevention and Enteral Access Total Production Capacity (2016-2026)
1.5.2 Global Infection Prevention and Enteral Access Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Infection Prevention and Enteral Access Market Drivers
1.6.2 Infection Prevention and Enteral Access Market Restraints
1.6.3 Infection Prevention and Enteral Access Trends Analysis
2 Manufacturers Profiles
2.1 Cook Medical
2.1.1 Cook Medical Details
2.1.2 Cook Medical Major Business
2.1.3 Cook Medical Infection Prevention and Enteral Access Product and Services
2.1.4 Cook Medical Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Medtronic Plc
2.2.1 Medtronic Plc Details
2.2.2 Medtronic Plc Major Business
2.2.3 Medtronic Plc Infection Prevention and Enteral Access Product and Services
2.2.4 Medtronic Plc Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Boston Scientific Corporation
2.3.1 Boston Scientific Corporation Details
2.3.2 Boston Scientific Corporation Major Business
2.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Product and Services
2.3.4 Boston Scientific Corporation Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 CONMED Corporation
2.4.1 CONMED Corporation Details
2.4.2 CONMED Corporation Major Business
2.4.3 CONMED Corporation Infection Prevention and Enteral Access Product and Services
2.4.4 CONMED Corporation Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 CORPAK MedSystems
2.5.1 CORPAK MedSystems Details
2.5.2 CORPAK MedSystems Major Business
2.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Product and Services
2.5.4 CORPAK MedSystems Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 CR Bard
2.6.1 CR Bard Details
2.6.2 CR Bard Major Business
2.6.3 CR Bard Infection Prevention and Enteral Access Product and Services
2.6.4 CR Bard Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 ALCOR Scientific
2.7.1 ALCOR Scientific Details
2.7.2 ALCOR Scientific Major Business
2.7.3 ALCOR Scientific Infection Prevention and Enteral Access Product and Services
2.7.4 ALCOR Scientific Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Pacific Hospital Supply
2.8.1 Pacific Hospital Supply Details
2.8.2 Pacific Hospital Supply Major Business
2.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Product and Services
2.8.4 Pacific Hospital Supply Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Teleflexorporated
2.9.1 Teleflexorporated Details
2.9.2 Teleflexorporated Major Business
2.9.3 Teleflexorporated Infection Prevention and Enteral Access Product and Services
2.9.4 Teleflexorporated Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Vygon SA
2.10.1 Vygon SA Details
2.10.2 Vygon SA Major Business
2.10.3 Vygon SA Infection Prevention and Enteral Access Product and Services
2.10.4 Vygon SA Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Infection Prevention and Enteral Access Sales by Manufacturer
3.1 Global Infection Prevention and Enteral Access Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Infection Prevention and Enteral Access Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Infection Prevention and Enteral Access
3.4 Market Concentration Rate
3.4.1 Top 3 Infection Prevention and Enteral Access Manufacturer Market Share
3.4.2 Top 6 Infection Prevention and Enteral Access Manufacturer Market Share
3.5 Global Infection Prevention and Enteral Access Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Infection Prevention and Enteral Access Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Infection Prevention and Enteral Access Market Size by Region
4.1.1 Global Infection Prevention and Enteral Access Sales in Volume by Region (2016-2026)
4.1.2 Global Infection Prevention and Enteral Access Revenue by Region (2016-2026)
4.2 North America Infection Prevention and Enteral Access Revenue (2016-2026)
4.3 Europe Infection Prevention and Enteral Access Revenue (2016-2026)
4.4 Asia-Pacific Infection Prevention and Enteral Access Revenue (2016-2026)
4.5 South America Infection Prevention and Enteral Access Revenue (2016-2026)
4.6 Middle East and Africa Infection Prevention and Enteral Access Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Infection Prevention and Enteral Access Sales in Volume by Type (2016-2026)
5.2 Global Infection Prevention and Enteral Access Revenue by Type (2016-2026)
5.3 Global Infection Prevention and Enteral Access Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Infection Prevention and Enteral Access Sales in Volume by Application (2016-2026)
6.2 Global Infection Prevention and Enteral Access Revenue by Application (2016-2026)
6.3 Global Infection Prevention and Enteral Access Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Infection Prevention and Enteral Access Sales by Type (2016-2026)
7.2 North America Infection Prevention and Enteral Access Sales by Application (2016-2026)
7.3 North America Infection Prevention and Enteral Access Market Size by Country
7.3.1 North America Infection Prevention and Enteral Access Sales in Volume by Country (2016-2026)
7.3.2 North America Infection Prevention and Enteral Access Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Infection Prevention and Enteral Access Sales by Type (2016-2026)
8.2 Europe Infection Prevention and Enteral Access Sales by Application (2016-2026)
8.3 Europe Infection Prevention and Enteral Access Market Size by Country
8.3.1 Europe Infection Prevention and Enteral Access Sales in Volume by Country (2016-2026)
8.3.2 Europe Infection Prevention and Enteral Access Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Infection Prevention and Enteral Access Sales by Type (2016-2026)
9.2 Asia-Pacific Infection Prevention and Enteral Access Sales by Application (2016-2026)
9.3 Asia-Pacific Infection Prevention and Enteral Access Market Size by Region
9.3.1 Asia-Pacific Infection Prevention and Enteral Access Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Infection Prevention and Enteral Access Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Infection Prevention and Enteral Access Sales by Type (2016-2026)
10.2 South America Infection Prevention and Enteral Access Sales by Application (2016-2026)
10.3 South America Infection Prevention and Enteral Access Market Size by Country
10.3.1 South America Infection Prevention and Enteral Access Sales in Volume by Country (2016-2026)
10.3.2 South America Infection Prevention and Enteral Access Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Infection Prevention and Enteral Access Sales by Type (2016-2026)
11.2 Middle East & Africa Infection Prevention and Enteral Access Sales by Application (2016-2026)
11.3 Middle East & Africa Infection Prevention and Enteral Access Market Size by Country
11.3.1 Middle East & Africa Infection Prevention and Enteral Access Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Infection Prevention and Enteral Access Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Infection Prevention and Enteral Access Typical Distributors
12.3 Infection Prevention and Enteral Access Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Infection Prevention and Enteral Access Revenue by Type, (USD Million), 2021-2026
Table 2. Global Infection Prevention and Enteral Access Revenue by Application, (USD Million), 2021-2026
Table 3. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 4. Cook Medical Major Business
Table 5. Cook Medical Infection Prevention and Enteral Access Product and Services
Table 6. Cook Medical Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Medtronic Plc Basic Information, Manufacturing Base and Competitors
Table 8. Medtronic Plc Major Business
Table 9. Medtronic Plc Infection Prevention and Enteral Access Product and Services
Table 10. Medtronic Plc Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Boston Scientific Corporation Major Business
Table 13. Boston Scientific Corporation Infection Prevention and Enteral Access Product and Services
Table 14. Boston Scientific Corporation Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. CONMED Corporation Basic Information, Manufacturing Base and Competitors
Table 16. CONMED Corporation Major Business
Table 17. CONMED Corporation Infection Prevention and Enteral Access Product and Services
Table 18. CONMED Corporation Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. CORPAK MedSystems Basic Information, Manufacturing Base and Competitors
Table 20. CORPAK MedSystems Major Business
Table 21. CORPAK MedSystems Infection Prevention and Enteral Access Product and Services
Table 22. CORPAK MedSystems Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. CR Bard Basic Information, Manufacturing Base and Competitors
Table 24. CR Bard Major Business
Table 25. CR Bard Infection Prevention and Enteral Access Product and Services
Table 26. CR Bard Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. ALCOR Scientific Basic Information, Manufacturing Base and Competitors
Table 28. ALCOR Scientific Major Business
Table 29. ALCOR Scientific Infection Prevention and Enteral Access Product and Services
Table 30. ALCOR Scientific Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pacific Hospital Supply Basic Information, Manufacturing Base and Competitors
Table 32. Pacific Hospital Supply Major Business
Table 33. Pacific Hospital Supply Infection Prevention and Enteral Access Product and Services
Table 34. Pacific Hospital Supply Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Teleflexorporated Basic Information, Manufacturing Base and Competitors
Table 36. Teleflexorporated Major Business
Table 37. Teleflexorporated Infection Prevention and Enteral Access Product and Services
Table 38. Teleflexorporated Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Vygon SA Basic Information, Manufacturing Base and Competitors
Table 40. Vygon SA Major Business
Table 41. Vygon SA Infection Prevention and Enteral Access Product and Services
Table 42. Vygon SA Infection Prevention and Enteral Access Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Infection Prevention and Enteral Access Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Infection Prevention and Enteral Access Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Infection Prevention and Enteral Access, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Infection Prevention and Enteral Access Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Infection Prevention and Enteral Access Production Site of Key Manufacturer
Table 48. Global Infection Prevention and Enteral Access Sales by Region (2016-2021e) & (K Units)
Table 49. Global Infection Prevention and Enteral Access Sales by Region (2021-2026) & (K Units)
Table 50. Global Infection Prevention and Enteral Access Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Infection Prevention and Enteral Access Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Infection Prevention and Enteral Access Sales by Type (2016-2021e) & (K Units)
Table 53. Global Infection Prevention and Enteral Access Sales by Type (2021-2026) & (K Units)
Table 54. Global Infection Prevention and Enteral Access Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Infection Prevention and Enteral Access Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Infection Prevention and Enteral Access Price by Type (2016-2021e) & (USD/Unit)
Table 57. Global Infection Prevention and Enteral Access Price by Type (2021-2026) & (USD/Unit)
Table 58. Global Infection Prevention and Enteral Access Sales by Application (2016-2021e) & (K Units)
Table 59. Global Infection Prevention and Enteral Access Sales by Application (2021-2026) & (K Units)
Table 60. Global Infection Prevention and Enteral Access Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Infection Prevention and Enteral Access Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Infection Prevention and Enteral Access Price by Application (2016-2021e) & (USD/Unit)
Table 63. Global Infection Prevention and Enteral Access Price by Application (2021-2026) & (USD/Unit)
Table 64. North America Infection Prevention and Enteral Access Sales by Country (2016-2021e) & (K Units)
Table 65. North America Infection Prevention and Enteral Access Sales by Country (2021-2026) & (K Units)
Table 66. North America Infection Prevention and Enteral Access Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Infection Prevention and Enteral Access Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Infection Prevention and Enteral Access Sales by Type (2016-2021e) & (K Units)
Table 69. North America Infection Prevention and Enteral Access Sales by Type (2021-2026) & (K Units)
Table 70. North America Infection Prevention and Enteral Access Sales by Application (2016-2021e) & (K Units)
Table 71. North America Infection Prevention and Enteral Access Sales by Application (2021-2026) & (K Units)
Table 72. Europe Infection Prevention and Enteral Access Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Infection Prevention and Enteral Access Sales by Country (2021-2026) & (K Units)
Table 74. Europe Infection Prevention and Enteral Access Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Infection Prevention and Enteral Access Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Infection Prevention and Enteral Access Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Infection Prevention and Enteral Access Sales by Type (2021-2026) & (K Units)
Table 78. Europe Infection Prevention and Enteral Access Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Infection Prevention and Enteral Access Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Infection Prevention and Enteral Access Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Infection Prevention and Enteral Access Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Infection Prevention and Enteral Access Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Infection Prevention and Enteral Access Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Infection Prevention and Enteral Access Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Infection Prevention and Enteral Access Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Infection Prevention and Enteral Access Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Infection Prevention and Enteral Access Sales by Application (2021-2026) & (K Units)
Table 88. South America Infection Prevention and Enteral Access Sales by Country (2016-2021e) & (K Units)
Table 89. South America Infection Prevention and Enteral Access Sales by Country (2021-2026) & (K Units)
Table 90. South America Infection Prevention and Enteral Access Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Infection Prevention and Enteral Access Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Infection Prevention and Enteral Access Sales by Type (2016-2021e) & (K Units)
Table 93. South America Infection Prevention and Enteral Access Sales by Type (2021-2026) & (K Units)
Table 94. South America Infection Prevention and Enteral Access Sales by Application (2016-2021e) & (K Units)
Table 95. South America Infection Prevention and Enteral Access Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Infection Prevention and Enteral Access Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Infection Prevention and Enteral Access Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Infection Prevention and Enteral Access Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Infection Prevention and Enteral Access Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Infection Prevention and Enteral Access Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Infection Prevention and Enteral Access Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Infection Prevention and Enteral Access Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Infection Prevention and Enteral Access Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Infection Prevention and Enteral Access Typical Distributors
Table 107. Infection Prevention and Enteral Access Typical Customers
List of Figures
Figure 1. Infection Prevention and Enteral Access Picture
Figure 2. Global Infection Prevention and Enteral Access Sales Market Share by Type in 2020
Figure 3. Enteral Feeding Pumps
Figure 4. Enteral Feeding Tubes
Figure 5. Administration Reservoirs
Figure 6. Giving Sets
Figure 7. Enteral Syringes
Figure 8. Global Infection Prevention and Enteral Access Sales Market Share by Application in 2020
Figure 9. Oncology
Figure 10. Gastroenterology
Figure 11. Diabetes
Figure 12. Neurological Disorders
Figure 13. Hypermetabolism
Figure 14. Others
Figure 15. Global Infection Prevention and Enteral Access Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 16. Global Infection Prevention and Enteral Access Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Infection Prevention and Enteral Access Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Infection Prevention and Enteral Access Sales (2016-2026) & (K Units)
Figure 37. Global Infection Prevention and Enteral Access Production Capacity (2016-2026) & (K Units)
Figure 38. Global Infection Prevention and Enteral Access Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Infection Prevention and Enteral Access Market Drivers
Figure 40. Infection Prevention and Enteral Access Market Restraints
Figure 41. Infection Prevention and Enteral Access Market Trends
Figure 42. Global Infection Prevention and Enteral Access Sales Market Share by Manufacturer in 2020
Figure 43. Global Infection Prevention and Enteral Access Revenue Market Share by Manufacturer in 2020
Figure 44. Infection Prevention and Enteral Access Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Infection Prevention and Enteral Access Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Infection Prevention and Enteral Access Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Infection Prevention and Enteral Access Sales Market Share by Region (2016-2026)
Figure 48. Global Infection Prevention and Enteral Access Revenue Market Share by Region (2016-2026)
Figure 49. North America Infection Prevention and Enteral Access Revenue (2016-2026) & (USD Million)
Figure 50. Europe Infection Prevention and Enteral Access Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Infection Prevention and Enteral Access Revenue (2016-2026) & (USD Million)
Figure 52. South America Infection Prevention and Enteral Access Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Infection Prevention and Enteral Access Revenue (2016-2026) & (USD Million)
Figure 54. Global Infection Prevention and Enteral Access Sales Market Share by Type (2016-2026)
Figure 55. Global Infection Prevention and Enteral Access Revenue Market Share by Type (2016-2026)
Figure 56. Global Infection Prevention and Enteral Access Price by Type (2016-2026) & (USD/Unit)
Figure 57. Global Infection Prevention and Enteral Access Sales Market Share by Application (2016-2026)
Figure 58. Global Infection Prevention and Enteral Access Revenue Market Share by Application (2016-2026)
Figure 59. Global Infection Prevention and Enteral Access Price by Application (2016-2026) & (USD/Unit)
Figure 60. North America Infection Prevention and Enteral Access Sales Market Share by Country (2016-2026)
Figure 61. North America Infection Prevention and Enteral Access Revenue Market Share by Country (2016-2026)
Figure 62. North America Infection Prevention and Enteral Access Sales Market Share by Type (2016-2026)
Figure 63. North America Infection Prevention and Enteral Access Sales Market Share by Application (2016-2026)
Figure 64. Europe Infection Prevention and Enteral Access Sales Market Share by Country (2016-2026)
Figure 65. Europe Infection Prevention and Enteral Access Revenue Market Share by Country (2016-2026)
Figure 66. Europe Infection Prevention and Enteral Access Sales Market Share by Type (2016-2026)
Figure 67. Europe Infection Prevention and Enteral Access Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Infection Prevention and Enteral Access Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Infection Prevention and Enteral Access Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Infection Prevention and Enteral Access Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Infection Prevention and Enteral Access Sales Market Share by Application (2016-2026)
Figure 72. South America Infection Prevention and Enteral Access Sales Market Share by Country (2016-2026)
Figure 73. South America Infection Prevention and Enteral Access Revenue Market Share by Country (2016-2026)
Figure 74. South America Infection Prevention and Enteral Access Sales Market Share by Type (2016-2026)
Figure 75. South America Infection Prevention and Enteral Access Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Infection Prevention and Enteral Access Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Infection Prevention and Enteral Access Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Infection Prevention and Enteral Access Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Infection Prevention and Enteral Access Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source